Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 8:01 PM ET

Date/Time Source News Release
06/10/2025 04:00 PM EDT GlobeNewswire XPro(TM) Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alzheimer's Disease: Supported by Department of Defense
05/14/2025 08:00 AM EDT GlobeNewswire INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference
05/08/2025 04:10 PM EDT GlobeNewswire INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update
05/05/2025 07:00 AM EDT GlobeNewswire INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th
04/16/2025 07:00 AM EDT GlobeNewswire INmune Bio Receives Favorable Patentability Opinion for CORDStrom(TM) Platform Technology
04/14/2025 08:00 AM EDT GlobeNewswire INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom(TM) Manufacturing for Commercial Readiness
04/01/2025 07:00 AM EDT GlobeNewswire INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study
03/27/2025 04:05 PM EDT GlobeNewswire INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update
03/24/2025 08:00 AM EDT GlobeNewswire INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025
02/12/2025 07:00 AM EST GlobeNewswire INmune Bio Opens Phase II in High Dose Cohort of INKmune(TM) Trial in Prostate Cancer
Page

Additional News

As of June 12, 2025 • 8:01 PM ET

Date/Time Source News Release
06/10/2025 04:48 PM EDT Stock Traders Daily (INMB) On The My Stocks Page
05/18/2025 08:20 PM EDT Stock Traders Daily Where are the Opportunities in (INMB)
05/15/2025 05:28 PM EDT SeekingAlpha INmune Bio: XPro Trial Readout In Alzheimer's Disease Offers Big Opportunity
05/10/2025 03:57 AM EDT SeekingAlpha INmune Bio, Inc. (INMB) Q1 2025 Earnings Call Transcript
05/08/2025 05:07 PM EDT SeekingAlpha INmune Bio GAAP EPS of -$0.43 beats by $0.04, revenue of $0.05M
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - INmune Bio Inc.
04/21/2025 10:00 AM EDT SeekingAlpha Pz-Cel Has Massive Potential For RDEB Patients
04/14/2025 12:43 PM EDT SeekingAlpha INmune Bio Partners with Cell and Gene Therapy Catapult
03/27/2025 08:15 PM EDT SeekingAlpha INmune Bio anticipates Alzheimer's trial results within 100 days while advancing therapeutic platforms
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.